Clinical Trials Browser

Phase 1/2 × Erlotinib Hydrochloride × Other neoplasm × Clear all

NCT00314262 2014-10-24

Phase I/II Study of Chemoprevention With EGFR and COX-2 Inhibitor

Phase 1/2 Completed

17 enrolled 7 charts

Precancerous Conditions